Debate: NGS Testing for All Patients With GI Cancers? - Not Yet
Debate: NGS Testing for All Patients With GI Cancers? - Not Yet
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Debate: NGS Testing for All Patients With GI Cancers? - Yes

Debate: NGS Testing for All Patients With GI Cancers? - Yes

|
Debate: NGS Testing for All Patients With GI Cancers? - Not Yet

Debate: NGS Testing for All Patients With GI Cancers? - Not Yet

|
All Patients With GI Cancers Should Undergo NGS

All Patients With GI Cancers Should Undergo NGS

|
Is broad NGS testing useful in patients with metastatic colorectal cancer? - Pro

Is broad NGS testing useful in patients with metastatic colorectal cancer? - Pro

|
Tanios S. Bekaii-Saab, MD, on Next-Generation Sequencing for Gastrointestinal Cancer

Tanios S. Bekaii-Saab, MD, on Next-Generation Sequencing for Gastrointestinal Cancer

|
Familial cancer syndromes in GI cancers: Who should be tested and why?

Familial cancer syndromes in GI cancers: Who should be tested and why?

|
Recent updates in Diagnostics of Solid Organ Tumors

Recent updates in Diagnostics of Solid Organ Tumors

|
Novel therapies beyond immunotherapy for GI Malignancies

Novel therapies beyond immunotherapy for GI Malignancies

|
Next-Generation Sequencing and Molecular Subsets in Metastatic Colorectal Cancer

Next-Generation Sequencing and Molecular Subsets in Metastatic Colorectal Cancer

|
Understanding the Fundamentals: Next Generation Sequencing (NGS) panels - Maren Scheuner

Understanding the Fundamentals: Next Generation Sequencing (NGS) panels - Maren Scheuner

|
Stephen Lyle - Personalized medicine

Stephen Lyle - Personalized medicine

|
Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No

Debate: Are novel targets such as HER2 ready for prime time in colorectal cancer? - No

|
The Importance of NGS Testing in NSCLC

The Importance of NGS Testing in NSCLC

|
Debate - NACT versus Upfront Surgery for resectable pancreatic cancer

Debate - NACT versus Upfront Surgery for resectable pancreatic cancer

|
Keynote - Cancer Immunology (Carl H. June)

Keynote - Cancer Immunology (Carl H. June)

|
"Is Progress in Treatment Possible for Rare GI Tumor?" by Amit Mahipal, MBBS, MPH

"Is Progress in Treatment Possible for Rare GI Tumor?" by Amit Mahipal, MBBS, MPH

|
Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer

Tumor Molecular Testing—Making Sense of New Precision Medicine Testing Options for Cancer

|
2020 MPG + CP Keynote 1: Colin Pritchard, MD, PhD

2020 MPG + CP Keynote 1: Colin Pritchard, MD, PhD

|
Metastatic Cholangiocarcinoma: Targeted Therapy and NGS

Metastatic Cholangiocarcinoma: Targeted Therapy and NGS

|
Keynote Lecture: The Microbiome in GI Cancer - How Relevant is it?

Keynote Lecture: The Microbiome in GI Cancer - How Relevant is it?

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa